Advanced Search
Contact | Corporate | Help

Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer

Sponsors:
  • Eli Lilly and Company
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: enzastaurin
  • Drug: bevacizumab
  • Drug: paclitaxel
  • Drug: placebo
Enrollment:
2

Additional information about NCT00536939.


SourceSolution © 2008-2012